Literature DB >> 35340285

A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins.

Nicolas Bery1, Terry H Rabbitts2.   

Abstract

Targeting hard-to-drug proteins, such as proteins functioning by protein-protein interactions (PPIs) with small molecules, is difficult because of the lack of well-defined pockets. Fragment or computational-based methods are usually employed for the discovery of such compounds, but no generic method is available to quickly identify small molecules interfering with PPIs. Here, we provide a protocol describing a generic method to discover small molecules inhibiting the interaction between an intracellular antibody and its target, in particular for proteins that are hard to make in recombinant form. This protocol reports a versatile and generic method that can be applied to any target/intracellular antibody. Because it is a cell-based assay, it identifies chemical matters that are already displaying advantageous cell permeability properties. Graphic abstract: Cell-based intracellular antibody-guided small molecule screening.
Copyright © 2022 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Antibody-derived compound; BRET; Cell-based screening; Chromosomal translocation proteins; Hard-to-drug targets; Intracellular antibody

Year:  2022        PMID: 35340285      PMCID: PMC8899552          DOI: 10.21769/BioProtoc.4324

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

1.  Bioluminescence Resonance Energy Transfer 2 (BRET2)-Based RAS Biosensors to Characterize RAS Inhibitors.

Authors:  Nicolas Bery; Terence H Rabbitts
Journal:  Curr Protoc Cell Biol       Date:  2019-02-15

2.  A Targeted Protein Degradation Cell-Based Screening for Nanobodies Selective toward the Cellular RHOB GTP-Bound Conformation.

Authors:  Nicolas Bery; Laura Keller; Marjorie Soulié; Rémi Gence; Anne-Laure Iscache; Julia Cherier; Stéphanie Cabantous; Olivier Sordet; Isabelle Lajoie-Mazenc; Jean-Denis Pedelacq; Gilles Favre; Aurélien Olichon
Journal:  Cell Chem Biol       Date:  2019-09-12       Impact factor: 8.116

3.  Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.

Authors:  Tomoyuki Tanaka; Helen Sewell; Simon Waters; Simon E V Phillips; Terence H Rabbitts
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

4.  Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange.

Authors:  Sandrine Guillard; Paulina Kolasinska-Zwierz; Judit Debreczeni; Jason Breed; Jing Zhang; Nicolas Bery; Rose Marwood; Jon Tart; Ross Overman; Pawel Stocki; Bina Mistry; Christopher Phillips; Terence Rabbitts; Ronald Jackson; Ralph Minter
Journal:  Nat Commun       Date:  2017-07-14       Impact factor: 14.919

5.  Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment.

Authors:  Camilo E Quevedo; Abimael Cruz-Migoni; Nicolas Bery; Ami Miller; Tomoyuki Tanaka; Donna Petch; Carole J R Bataille; Lydia Y W Lee; Phillip S Fallon; Hanna Tulmin; Matthias T Ehebauer; Narcis Fernandez-Fuentes; Angela J Russell; Stephen B Carr; Simon E V Phillips; Terence H Rabbitts
Journal:  Nat Commun       Date:  2018-08-09       Impact factor: 14.919

6.  BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions.

Authors:  Nicolas Bery; Abimael Cruz-Migoni; Carole Jr Bataille; Camilo E Quevedo; Hanna Tulmin; Ami Miller; Angela Russell; Simon Ev Phillips; Stephen B Carr; Terence H Rabbitts
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

7.  KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe.

Authors:  Nicolas Bery; Sandrine Legg; Judit Debreczeni; Jason Breed; Kevin Embrey; Christopher Stubbs; Paulina Kolasinska-Zwierz; Nathalie Barrett; Rose Marwood; Jo Watson; Jon Tart; Ross Overman; Ami Miller; Christopher Phillips; Ralph Minter; Terence H Rabbitts
Journal:  Nat Commun       Date:  2019-06-13       Impact factor: 14.919

8.  Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody.

Authors:  Tomoyuki Tanaka; Jemima Thomas; Rob Van Montfort; Ami Miller; Terry Rabbitts
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

9.  A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2.

Authors:  Nicolas Bery; Carole J R Bataille; Angela Russell; Angela Hayes; Florence Raynaud; Sabine Milhas; Sneha Anand; Hanna Tulmin; Ami Miller; Terence H Rabbitts
Journal:  Sci Adv       Date:  2021-04-09       Impact factor: 14.136

10.  Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.

Authors:  Tomoyuki Tanaka; Roger L Williams; Terence H Rabbitts
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

  10 in total
  1 in total

Review 1.  Antibody-Based Approaches to Target Pancreatic Tumours.

Authors:  Marie Sorbara; Pierre Cordelier; Nicolas Bery
Journal:  Antibodies (Basel)       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.